TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,149 | -97.2% | 35,699 | -95.1% | 0.00% | -97.6% |
| Q2 2023 | $11,272,120 | +1115.6% | 733,862 | +1679.9% | 0.04% | +192.9% |
| Q1 2023 | $927,285 | -91.3% | 41,231 | -91.9% | 0.01% | -92.8% |
| Q4 2022 | $10,663,955 | +27.9% | 507,083 | +49.8% | 0.19% | +22.0% |
| Q3 2022 | $8,339,000 | +65.6% | 338,424 | +62.8% | 0.16% | +14.4% |
| Q2 2022 | $5,037,000 | +17.4% | 207,895 | +24.8% | 0.14% | +20.9% |
| Q1 2022 | $4,291,000 | +220.7% | 166,520 | +286.4% | 0.12% | +173.8% |
| Q4 2021 | $1,338,000 | +303.0% | 43,095 | +89.2% | 0.04% | +281.8% |
| Q2 2021 | $332,000 | +50.2% | 22,778 | +157.5% | 0.01% | -15.4% |
| Q1 2021 | $221,000 | – | 8,847 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
| Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
| Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
| GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
| ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
| HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
| MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
| Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
| Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |